$4.600
-0.459 (-9.98%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
TNXP-Prognose durch Analyse ähnlicher Charts
Alphio's TNXP stock price prediction model matches the current Tonix Pharmaceuticals Holding Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.54 (-1.41%). The 1-week path is $4.50 (-2.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Tonix Pharmaceuticals Holding Corp-Aktien kaufen?
Tonix Pharmaceuticals appears to be a good buy right now due to its current price of $5.15, significantly below its 52-week high of $20.56, indicating potential for recovery. The company has shown strong revenue growth, with Q2 2026 net product revenue reaching $13.54 million, up from $2 million year-over-year. Additionally, the gross margin has improved to 94.81% in Q2 2026, reflecting operational efficiency. However, the main risk is the high net loss of $40.6 million in Q2 2026, which could impact future performance if not managed effectively.
TNXP schloss am Thursday bei $4.60, nachdem der Kurs -9.98% fallen
Tonix Pharmaceuticals Holding Corp (TNXP) last closed at $4.5999999, losing -9.98%. These facts feed the 1-day and 1-week TNXP price prediction above.
Analystenkonsens
Tonix Pharmaceuticals Holding Corp (TNXP): 3 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Tonix Pharmaceuticals Holding Corp (TNXP) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf TNXP am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für TNXP
Historically the probability of a positive November return for TNXP is 0.00%. June offers the highest probability of a positive month at 33.33%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für TNXP
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $37.47 | $42.55 | $47.57 | +824.91% |
| Dec 2026 | $41.35 | $45.49 | $47.56 | +888.97% |
Für 2026 wird für Tonix Pharmaceuticals Holding Corp (TNXP) eine Spanne von $37.47 bis $47.57 projiziert.
Monatsprognose 2026 für Tonix Pharmaceuticals Holding Corp
Im Nov 2026 wird für Tonix Pharmaceuticals Holding Corp ein Durchschnitt von $42.55 erwartet, mit einem Tief von $37.47 und einem Hoch von $47.57.
Im Dec 2026 wird für Tonix Pharmaceuticals Holding Corp ein Durchschnitt von $45.49 erwartet, mit einem Tief von $41.35 und einem Hoch von $47.56.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.